Abattis Bioceuticals Corp (ATTBF)
0.00
USD |
OTCM |
May 24, 16:00
Abattis Bioceuticals Total Liabilities (Quarterly): 6.492M for Sept. 30, 2019
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2019 | 6.492M |
| June 30, 2019 | 6.705M |
| March 31, 2019 | 0.2439M |
| December 31, 2018 | 0.2803M |
| September 30, 2018 | 0.2346M |
| June 30, 2018 | 1.035M |
| March 31, 2018 | 3.049M |
| December 31, 2017 | 0.4058M |
| September 30, 2017 | 0.3532M |
| June 30, 2017 | 0.5483M |
| March 31, 2017 | 0.6532M |
| December 31, 2016 | 0.49M |
| September 30, 2016 | 0.8045M |
| June 30, 2016 | 0.5785M |
| March 31, 2016 | 0.7483M |
| December 31, 2015 | 0.6991M |
| September 30, 2015 | 0.8469M |
| June 30, 2015 | 1.388M |
| March 31, 2015 | 1.341M |
| December 31, 2014 | 1.332M |
| September 30, 2014 | 1.130M |
| June 30, 2014 | 0.6667M |
| Date | Value |
|---|---|
| March 31, 2014 | 1.119M |
| December 31, 2013 | 1.124M |
| September 30, 2013 | 1.038M |
| June 30, 2013 | 1.012M |
| March 31, 2013 | 0.9229M |
| December 31, 2012 | 0.7682M |
| September 30, 2012 | 0.7151M |
| June 30, 2012 | 0.452M |
| March 31, 2012 | 0.4062M |
| December 31, 2011 | 0.1943M |
| September 30, 2011 | 0.1228M |
| June 30, 2011 | 0.3113M |
| March 31, 2011 | 0.2301M |
| December 31, 2010 | 0.1705M |
| September 30, 2010 | 0.419M |
| June 30, 2010 | 0.2666M |
| December 31, 2009 | 0.0696M |
| September 30, 2009 | 0.1565M |
| June 30, 2009 | 0.1815M |
| March 31, 2009 | 0.6092M |
| September 30, 2008 | 0.0524M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.492M
Minimum
Sep 2019
6.705M
Maximum
Jun 2019
6.598M
Average
6.598M
Median
Total Liabilities (Quarterly) Benchmarks
| Acasti Pharma Inc | 11.50M |
| Aurinia Pharmaceuticals Inc | 170.11M |
| Edesa Biotech Inc | 2.151M |
| Lexaria Bioscience Corp | 0.2042M |
| Liminal Biosciences Inc (DELISTED) | 7.790M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.55M |
| Shareholders Equity (Quarterly) | 8.368M |